Skip to main content
. 2020 Jan 23;62:6. doi: 10.1186/s13028-020-0504-y

Table 1.

AMR profiles of Aeromonas isolates

Antimicrobials No. of resistant isolates (%) Chi-square index (χ2)
A. hydrophila A. sobria A. caviae Total
Cloxacillin 53 (100) 31 (100) 11 (100) 95 (100) /
Spiramycin 53 (100) 31 (100) 11 (100) 95 (100) /
Tilmicosin 53 (100) 31 (100) 11 (100) 95 (100) /
Ampicillin* 53 (100) 31 (100) 10 (90.9) 94 (98.9) 7.72
Tylosin 53 (100) 30 (96.8) 11 (100) 94 (98.9) 2.09
Penicillin 52 (98.1) 30 (96.8) 11 (100) 93 (97.9) 0.44
Sulfadiazine* 53 (100) 28 (90.3) 11 (100) 92 (96.8) 6.40
Amoxicillin 52 (98.1) 30 (96.8) 10 (90.9) 92 (96.8) 1.55
Tiamulin** 48 (90.6) 22 (71.0) 11 (100) 81 (85.3) 8.13
Neomycin** 27 (50.9) 26 (83.9) 4 (36.4) 57 (60.0) 11.73
Erythromycin*** 35 (66.0) 9 (29.0) 11 (100) 55 (57.9) 20.04
Cephaloridine*** 38 (71.7) 3 (9.7) 10 (90.9) 51 (53.7) 37.19
AMC 27 (50.9) 11 (35.5) 5 (45.5) 43 (45.3) 1.89
Apramycin*** 16 (30.2) 23 (74.2) 0 39 (41.1) 24.32
Tetracycline** 12 (22.6) 1 (3.2) 5 (45.5) 18 (8.9) 10.49
SXT** 14 (26.4) 0 2 (18.2) 16 (16.8) 9.76
Nalidixic acid* 12 (22.6) 0 3 (27.3) 15 (15.8) 8.77
Thiamphenicol* 11 (20.8) 0 2 (18.2) 13 (13.7) 7.35
Kanamycin 5 (9.4) 6 (19.4) 0 11 (11.6) 3.51
Danofloxacin 7 (13.2) 0 2 (18.2) 9 (9.5) 5.08
Enrofloxacin*** 4 (7.5) 0 4 (36.4) 8 (8.4) 14.04
Flumequine 5 (9.4) 0 2 (18.2) 7 (7.4) 4.68
Ceftiofur*** 1 (1.9) 1 (3.2) 4 (36.4) 6 (6.3) 19.04
Aminosidine* 1 (1.9) 5 (16.1) 0 6 (6.3) 7.54
Colistin 4 (7.5) 2 (6.5) 0 6 (6.3) 0.88
Doxycycline** 2 (3.8) 0 3 (27.3) 5 (5.3) 12.64
Gentamicin 3 (5.7) 0 0 3 (3.2) 2.45
Marbocyl 3 (5.7) 0 0 3 (3.2) 2.45
Florfenicol 2 (3.8) 0 1 (9.1) 3 (3.2) 2.34
Cefquinome 0 0 0 0 /

Significant differences between Aeromonas complexes were indicated by: * P < 0.05, ** P < 0.01, *** P < 0.001